Brief: Neubase Therapeutics Issues Statement Regarding Filing By Shareholder
08/09/2023 12:31
Sept 8 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS ISSUES STATEMENT REGARDING FILING BY
SHAREHOLDER
* NEUBASE THERAPEUTICS INC- REMAINS COMMITTED COMPLETING ITS
COMPREHENSIVE EXPLORATION OF STRATEGIC ALTERNATIVES FOCUSED ON
MAXIMIZING SHAREHOLDER VALUE
* NEUBASE THERAPEUTICS INC- DOES NOT BELIEVE THAT
SHAREHOLDER
VALUE WILL BE ENHANCED BY ISSUING SPECIAL $1 PER SHARE DIVIDEND
SYMETRYX REQUESTED
* NEUBASE THERAPEUTICS INC- MANAGEMENT WILL CONTINUE TO SEEK
AN
OPEN AND ACTIVE DIALOGUE WITH ITS SHAREHOLDERS, INCLUDING
SYMETRYX
Source text for Eikon: ID:nGNX8x4cj6
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet